Recent Articles

Patent Filing Litigations Continue to Increase Despite the COVID-19 Pandemic
Looking back at the past decade, in 2013, filings of patent lawsuits in the United States were at an...

Azami Global

Getting the Most from Medical-Use Claims in Australia
Australia stands apart from many other key jurisdictions in allowing first and second medical use claims...

Dr Sarah Hennebry

FPA Patent Attorneys
Plausibility and Undue Burden: A New Look at Insufficiency after FibroGen v Akebia
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics...

Paul Harris

Patent Examination Practice for Novelty in the Field of Life Sciences in China
When evaluating the novelty of claims in life sciences and pharmaceutical, compared with EPO, the examination...

Guohua Tang and Qianhui Yang

Watson & Band
Notes to Patent Drafters: Common Issues with Broad Specifications in Canada
The Canadian Patent Act imposes an unyielding relationship between the requirement for a written...

Ted Yoo and Krishen Singh

Bennet Jones LLP
Prosecution Pathway for Pharma & Bio Patents in India
Prosecution pathway for pharma & bio patents in india – part 1 The Indian pharmaceutical industry,...

Gaurav Mishra

BananaIP Counsels
1 2 3 5

Get our insights delivered straight to your inbox.